Article Information
History
- December 11, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Emma Simonsen, MD1,
- Lars Christian Lund, MD PhD1,
- Martin Thomsen Ernst, MSc1,
- Vidar Hjellvik, PhD2,
- Laszlo Hegedüs, MD DMSc3,4,
- Steffen Hamann, MD PhD5,6,
- Øystein Kalsnes Jørstad, MD PhD7,
- Hanne Løvdal Gulseth, MD PhD2,
- Øystein Karlstad, MSc PhD2 and
- Anton Pottegård, MSc PhD DMSc1,*
- 1Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public health, University of Southern Denmark, Odense, Denmark
- 2Department of Chronic Diseases, Norwegian Institute of Public Health, Oslo, Norway
- 3Department of Endocrinology, Odense University Hospital, Odense, Denmark
- 4Department of Regional Health Research, University of Southern Denmark, Odense, Denmark
- 5Department of Ophthalmology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
- 6Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 7Department of Ophthalmology, Oslo University Hospital, Oslo, Norway and Faculty of Medicine, University of Oslo, Oslo, Norway
- ↵*Correspondence,
Anton Pottegård, Professor, Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Campusvej 55, DK-5230 Odense M, Denmark, E-mail: apottegaard{at}health.sdu.dk, Phone: 0045 28913340
Posted December 11, 2024.
Use of semaglutide and risk of non-arteritic anterior ischemic optic neuropathy: A Danish–Norwegian cohort study
